Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global Cobamamide for Injection Market Research Report 2022
1 Cobamamide for Injection Market Overview1.1 Product Overview and Scope of Cobamamide for Injection
1.2 Cobamamide for Injection Segment by Type
1.2.1 Global Cobamamide for Injection Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 0.5mg
1.2.3 1.0mg
1.2.4 1.5mg
1.3 Cobamamide for Injection Segment by Application
1.3.1 Global Cobamamide for Injection Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Global Cobamamide for Injection Market Size Estimates and Forecasts
1.4.1 Global Cobamamide for Injection Revenue 2017-2028
1.4.2 Global Cobamamide for Injection Sales 2017-2028
1.4.3 Cobamamide for Injection Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cobamamide for Injection Market Competition by Manufacturers
2.1 Global Cobamamide for Injection Sales Market Share by Manufacturers (2017-2022)
2.2 Global Cobamamide for Injection Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Cobamamide for Injection Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Cobamamide for Injection Manufacturing Sites, Area Served, Product Type
2.5 Cobamamide for Injection Market Competitive Situation and Trends
2.5.1 Cobamamide for Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cobamamide for Injection Players Market Share by Revenue
2.5.3 Global Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cobamamide for Injection Retrospective Market Scenario by Region
3.1 Global Cobamamide for Injection Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Cobamamide for Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Cobamamide for Injection Market Facts & Figures by Country
3.3.1 North America Cobamamide for Injection Sales by Country
3.3.2 North America Cobamamide for Injection Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cobamamide for Injection Market Facts & Figures by Country
3.4.1 Europe Cobamamide for Injection Sales by Country
3.4.2 Europe Cobamamide for Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cobamamide for Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Cobamamide for Injection Sales by Region
3.5.2 Asia Pacific Cobamamide for Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cobamamide for Injection Market Facts & Figures by Country
3.6.1 Latin America Cobamamide for Injection Sales by Country
3.6.2 Latin America Cobamamide for Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cobamamide for Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Cobamamide for Injection Sales by Country
3.7.2 Middle East and Africa Cobamamide for Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cobamamide for Injection Historic Market Analysis by Type
4.1 Global Cobamamide for Injection Sales Market Share by Type (2017-2022)
4.2 Global Cobamamide for Injection Revenue Market Share by Type (2017-2022)
4.3 Global Cobamamide for Injection Price by Type (2017-2022)
5 Global Cobamamide for Injection Historic Market Analysis by Application
5.1 Global Cobamamide for Injection Sales Market Share by Application (2017-2022)
5.2 Global Cobamamide for Injection Revenue Market Share by Application (2017-2022)
5.3 Global Cobamamide for Injection Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Haerbin Medisan
6.1.1 Haerbin Medisan Corporation Information
6.1.2 Haerbin Medisan Description and Business Overview
6.1.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Haerbin Medisan Cobamamide for Injection Product Portfolio
6.1.5 Haerbin Medisan Recent Developments/Updates
6.2 North China Pharmaceutical Group
6.2.1 North China Pharmaceutical Group Corporation Information
6.2.2 North China Pharmaceutical Group Description and Business Overview
6.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue and Gross Margin (2017-2022)
6.2.4 North China Pharmaceutical Group Cobamamide for Injection Product Portfolio
6.2.5 North China Pharmaceutical Group Recent Developments/Updates
6.3 Chongqing Yaoyou Pharmaceutical
6.3.1 Chongqing Yaoyou Pharmaceutical Corporation Information
6.3.2 Chongqing Yaoyou Pharmaceutical Description and Business Overview
6.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Portfolio
6.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
6.4 Hainan Star Pharmaceutical
6.4.1 Hainan Star Pharmaceutical Corporation Information
6.4.2 Hainan Star Pharmaceutical Description and Business Overview
6.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hainan Star Pharmaceutical Cobamamide for Injection Product Portfolio
6.4.5 Hainan Star Pharmaceutical Recent Developments/Updates
6.5 Hebei Zhitong Biopharmaceutical
6.5.1 Hebei Zhitong Biopharmaceutical Corporation Information
6.5.2 Hebei Zhitong Biopharmaceutical Description and Business Overview
6.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Portfolio
6.5.5 Hebei Zhitong Biopharmaceutical Recent Developments/Updates
6.6 Jiangsu Jiuxu Pharmaceutical
6.6.1 Jiangsu Jiuxu Pharmaceutical Corporation Information
6.6.2 Jiangsu Jiuxu Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Portfolio
6.6.5 Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
6.7 Jiuquan Dadeli pharmaceutical
6.6.1 Jiuquan Dadeli pharmaceutical Corporation Information
6.6.2 Jiuquan Dadeli pharmaceutical Description and Business Overview
6.6.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Portfolio
6.7.5 Jiuquan Dadeli pharmaceutical Recent Developments/Updates
7 Cobamamide for Injection Manufacturing Cost Analysis
7.1 Cobamamide for Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cobamamide for Injection
7.4 Cobamamide for Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cobamamide for Injection Distributors List
8.3 Cobamamide for Injection Customers
9 Cobamamide for Injection Market Dynamics
9.1 Cobamamide for Injection Industry Trends
9.2 Cobamamide for Injection Market Drivers
9.3 Cobamamide for Injection Market Challenges
9.4 Cobamamide for Injection Market Restraints
10 Global Market Forecast
10.1 Cobamamide for Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cobamamide for Injection by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Cobamamide for Injection by Type (2023-2028)
10.2 Cobamamide for Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cobamamide for Injection by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Cobamamide for Injection by Application (2023-2028)
10.3 Cobamamide for Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cobamamide for Injection by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Cobamamide for Injection by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Cobamamide for Injection Market Research Report 2022
List of TablesTable 1. Global Cobamamide for Injection Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
Table 2. Global Cobamamide for Injection Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
Table 3. Global Cobamamide for Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Cobamamide for Injection Market Competitive Situation by Manufacturers in 2021
Table 5. Global Cobamamide for Injection Sales (Kg) of Key Manufacturers (2017-2022)
Table 6. Global Cobamamide for Injection Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Cobamamide for Injection Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Cobamamide for Injection Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Cobamamide for Injection Average Price (US$/g) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Cobamamide for Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Cobamamide for Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cobamamide for Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cobamamide for Injection as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cobamamide for Injection Sales by Region (2017-2022) & (Kg)
Table 16. Global Cobamamide for Injection Sales Market Share by Region (2017-2022)
Table 17. Global Cobamamide for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Cobamamide for Injection Revenue Market Share by Region (2017-2022)
Table 19. North America Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 20. North America Cobamamide for Injection Sales Market Share by Country (2017-2022)
Table 21. North America Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Cobamamide for Injection Revenue Market Share by Country (2017-2022)
Table 23. Europe Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 24. Europe Cobamamide for Injection Sales Market Share by Country (2017-2022)
Table 25. Europe Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Cobamamide for Injection Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Cobamamide for Injection Sales by Region (2017-2022) & (Kg)
Table 28. Asia Pacific Cobamamide for Injection Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Cobamamide for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Cobamamide for Injection Revenue Market Share by Region (2017-2022)
Table 31. Latin America Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 32. Latin America Cobamamide for Injection Sales Market Share by Country (2017-2022)
Table 33. Latin America Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Cobamamide for Injection Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 36. Middle East and Africa Cobamamide for Injection Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Cobamamide for Injection Revenue Market Share by Country (2017-2022)
Table 39. Global Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 40. Global Cobamamide for Injection Sales Market Share by Type (2017-2022)
Table 41. Global Cobamamide for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Cobamamide for Injection Revenue Share by Type (2017-2022)
Table 43. Global Cobamamide for Injection Price by Type (2017-2022) & (US$/g)
Table 44. Global Cobamamide for Injection Sales (Kg) by Application (2017-2022)
Table 45. Global Cobamamide for Injection Sales Market Share by Application (2017-2022)
Table 46. Global Cobamamide for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Cobamamide for Injection Revenue Share by Application (2017-2022)
Table 48. Global Cobamamide for Injection Price by Application (2017-2022) & (US$/g)
Table 49. Haerbin Medisan Corporation Information
Table 50. Haerbin Medisan Description and Business Overview
Table 51. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 52. Haerbin Medisan Cobamamide for Injection Product
Table 53. Haerbin Medisan Recent Developments/Updates
Table 54. North China Pharmaceutical Group Corporation Information
Table 55. North China Pharmaceutical Group Description and Business Overview
Table 56. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 57. North China Pharmaceutical Group Cobamamide for Injection Product
Table 58. North China Pharmaceutical Group Recent Developments/Updates
Table 59. Chongqing Yaoyou Pharmaceutical Corporation Information
Table 60. Chongqing Yaoyou Pharmaceutical Description and Business Overview
Table 61. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 62. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product
Table 63. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 64. Hainan Star Pharmaceutical Corporation Information
Table 65. Hainan Star Pharmaceutical Description and Business Overview
Table 66. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 67. Hainan Star Pharmaceutical Cobamamide for Injection Product
Table 68. Hainan Star Pharmaceutical Recent Developments/Updates
Table 69. Hebei Zhitong Biopharmaceutical Corporation Information
Table 70. Hebei Zhitong Biopharmaceutical Description and Business Overview
Table 71. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 72. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product
Table 73. Hebei Zhitong Biopharmaceutical Recent Developments/Updates
Table 74. Jiangsu Jiuxu Pharmaceutical Corporation Information
Table 75. Jiangsu Jiuxu Pharmaceutical Description and Business Overview
Table 76. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 77. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product
Table 78. Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
Table 79. Jiuquan Dadeli pharmaceutical Corporation Information
Table 80. Jiuquan Dadeli pharmaceutical Description and Business Overview
Table 81. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 82. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product
Table 83. Jiuquan Dadeli pharmaceutical Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Cobamamide for Injection Distributors List
Table 87. Cobamamide for Injection Customers List
Table 88. Cobamamide for Injection Market Trends
Table 89. Cobamamide for Injection Market Drivers
Table 90. Cobamamide for Injection Market Challenges
Table 91. Cobamamide for Injection Market Restraints
Table 92. Global Cobamamide for Injection Sales Forecast by Type (2023-2028) & (Kg)
Table 93. Global Cobamamide for Injection Sales Market Share Forecast by Type (2023-2028)
Table 94. Global Cobamamide for Injection Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Cobamamide for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 96. Global Cobamamide for Injection Sales Forecast by Application (2023-2028) & (Kg)
Table 97. Global Cobamamide for Injection Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Cobamamide for Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. Global Cobamamide for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 100. Global Cobamamide for Injection Sales Forecast by Region (2023-2028) & (Kg)
Table 101. Global Cobamamide for Injection Sales Market Share Forecast by Region (2023-2028)
Table 102. Global Cobamamide for Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 103. Global Cobamamide for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cobamamide for Injection
Figure 2. Global Cobamamide for Injection Market Share by Type in 2021 & 2028
Figure 3. 0.5mg Product Picture
Figure 4. 1.0mg Product Picture
Figure 5. 1.5mg Product Picture
Figure 6. Global Cobamamide for Injection Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Drug Store
Figure 9. Other
Figure 10. Global Cobamamide for Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Cobamamide for Injection Market Size (2017-2028) & (US$ Million)
Figure 12. Global Cobamamide for Injection Sales (2017-2028) & (Kg)
Figure 13. Cobamamide for Injection Sales Share by Manufacturers in 2021
Figure 14. Global Cobamamide for Injection Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Cobamamide for Injection Players: Market Share by Revenue in 2021
Figure 16. Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Cobamamide for Injection Sales Market Share by Region (2017-2022)
Figure 18. Global Cobamamide for Injection Sales Market Share by Region in 2021
Figure 19. Global Cobamamide for Injection Revenue Market Share by Region (2017-2022)
Figure 20. Global Cobamamide for Injection Revenue Market Share by Region in 2021
Figure 21. U.S. Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Cobamamide for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Cobamamide for Injection by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Cobamamide for Injection
Figure 47. Manufacturing Process Analysis of Cobamamide for Injection
Figure 48. Cobamamide for Injection Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Keyplayers in Global Cobamamide for Injection Market Research Report 2022
Haerbin MedisanNorth China Pharmaceutical Group
Chongqing Yaoyou Pharmaceutical
Hainan Star Pharmaceutical
Hebei Zhitong Biopharmaceutical
Jiangsu Jiuxu Pharmaceutical
Jiuquan Dadeli pharmaceutical
REQUEST TABLES & FIGURES MENTIONED IN THIS REPORT
